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Abstract 
Gene expression represents a fundamental interface between genes and environment in the 
development and ongoing plasticity of the human organism. Individual differences in gene expression 
are likely to underpin much of human diversity, including psychiatric illness. Gene expression 
shows a distinct regulatory pattern in different tissues. Therefore, brain tissue analysis provides 
insights into brain disorder mechanisms. Furthermore, mechanistic understanding of gene 
regulatory pattern can be provided through studying the underlying relationships as a complex 
network. Identification of brain specific gene relationships provides a complementary framework 
in which to tackle the complex dysregulations that occur in neuropsychiatric and other neurological 
disorders. 
Using a systems approach established in Mendelian randomization and Bayesian Network, we integrated 
genetic and transcriptomic data from the common-mind consortium and identified transcriptomic 
causal networks in observational studies. Focusing on Schizophrenia disorder, we identified high impact 
genes and revealed their underlying pathways in brain tissue. In addition, we generated novel 
hypotheses including genes as causes of the schizophrenia-associated genes and new genes 
associated with Schizophrenia. This approach may facilitate a better understanding of the disease 
mechanism that is complementary to molecular experimental studies especially for complex systems 
and large-scale data sets. 
Keywords: causal Network, systems approach, transcriptomic pathway, intervention target, 
Schizophrenia 
Introduction 
Due to physical context of tissue environment, cells from different tissues exhibit unique functions that 
define tissue specific phenotype. These specific process and common processes among all cells that are 
essential for survival are ultimately controlled by gene regulatory networks.  Gene regulatory networks 
alter genes expression and control the extent of that expression. Therefore, focusing on brain tissue 
analysis provides specific understanding of activity and regulation of multiple systems in brain and 
consequently dysregulation of genes in neurological disorder, such as schizophrenia. 
Schizophrenia (SCZ) as a heritable complex mental disorder is a severe psychiatric disorder with a 
world-wide prevalence of 1% that is characterized by abnormalities in thought and cognition. Recently, 
multiple genetic studies, including linkage scans and their meta-analyses, candidate gene association 
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analyses, differential expression analyses and genome-wide association studies (GWAS) have 
investigated genes/markers and chromosomal regions for SCZ (Ng et al., 2009; International 
Schizophrenia Consortium et al., 2009; Shi et al., 2009; Stefansson et al., 2009; Ripke et al., 2014). 
These studies show that SCZ disorder involves changes in multiple genes, each conferring small and 
incremental risk that potentially converge in deregulated biological pathways, cellular functions and local 
circuit changes, eventually scaling up to brain region pathophysiology (Belmaker and Agam, 2008; Sibille 
and French, 2013). In addition, correlation based networks have been applied on schizophrenia 
candidate genes (He, Chen and Evans, 2007; Wright et al., 1999; Bullmore and Sporns, 2009; Fromer et 
al., 2016).  Such networks tend to result in many dependencies that arise from indirect interactions in the 
underlying anatomy and face limited success in finding functional genes and intervention targets 
(Sullivan, Kendler and Neale, 2003).  
Utilizing systems approaches established in recognition of hierarchal structure of many systems biology 
can provide conceptual clarity and biological accuracy to better understand disease mechanism. These 
applications narrow search space down to a subset of biological components with high impact on 
disease end points and identify underlying pathways and intervention targets with reproducible results 
(Yazdani et al., 2018). Since the connections among genes are disturbed in the patients with SCZ 
disorder, manipulating in intervention targets may reconnect the genes. These features facilitate a 
mechanistic understanding/causal interpretation (Yazdani et al., 2015; Yazdani et al., 2014; Pearl, 2000) 
and make systems approaches complementary to molecular experimental studies especially for complex 
systems and large-scale data sets.  
We here focused on integrating genomics and transcriptomics and utilized a systems approach called 
genome directed acyclic graph (the G-DAG algorithm) established in Mendelian Randomization and 
Bayesian graphical modeling (Yazdani et al., 2016a) with reproduced findings (Yazdani et al., 2018). The 
RNA sequence data were from post-mortem dorsolateral prefrontal cortex which controls complex, 
higher-level cognitive and executive functions. We modified the G-DAG algorithm and built a 
transcriptomic causal network which reveals the underling transcriptomic pathways. Across the network, 
we identified modules and individual genes with high impact in the system. Our examination of the 
transcriptomic network revealed that each gene pathway includes a small subset of genes in the system. 
Mapping the SCZ associated genes on the transcriptomic network, we identified modules related to SCZ 
and hypothesized the genes that are causes of the SCZ associated genes and consequently are 
intervention targets.  For instance, the gene MAS1 is identified as the cause of SCZ associated gene 
NRXN3. In addition, we hypothesized new genes associated with SCZ, such as GRIN3A, as well as new 
targets for intervention, such as COMT. Moreover, identification of underlying transcriptomic pathways 
reveals how the effect of the intervention spread in the system.  
An overview on application of Mendelian randomization/instrumental variables 
To gain sufficient understanding and predict behavior of a system, we utilize Mendelian randomization 
technique using genetic variants as instrumental variables, which recently has gained attentions in 
biomedical applications. Instrumental variable approaches control for unmeasured confounding relative to 
other approaches such as regression, matching, and propensity score methods (Dawid, 2007; Sheehan 
et al., 2008; Yazdani et al., 2016c). This feature leads to robust results with mechanistic understanding 
(i.e. causal interpretation) even in the presence of unmeasured confounders and reverse causation if the 
utilized genetic variants qualify as instrumental variables: 
1. Being associated with a transcript of interest (exposure) that is a potential cause of an outcome 
transcript. 
2. Not being associated with any confounders (measured and unmeasured) of the two transcripts of 
interest  
3. Not being associated with the transcript outcome directly but only through the transcript of 
interest.  
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These conditions are visualized in Figure 1 in a small scale.   
 
 
 
 
 
 
 
Figure 1. Visualization of instrumental variable assumptions. IV stands for instrumental variable. 
 
Genotype features such as pleiotropy, the presence of linkage disequilibrium, genetic heterogeneity, lack 
of knowledge about the confounders, and population stratification, may violate the assumptions of 
instrumental variable and bring limitations to application of genetic variants (Sheehan et al., 2008). 
Although the assumptions must be justified from background knowledge of the underlying biology and 
none of them are statistically testable, we can take some steps toward holding these assumptions. 
Evaluating the assumptions adds to the credibility of the analyses and there are some methods to this 
end. 
Some approaches aim to find a single genetic variant strongly correlated with the variable of interest. 
These approaches are limited to identify sufficient numbers of instrumental variables for a large-scale 
data set (Inouye et al., 2010) and possibility violate some of the assumptions due to the genotype 
features such as pleiotropic effect. Here, we focus on genome directed acyclic graph (G-DAG) algorithm 
that aims to hold the underlying assumptions through three main features as following:  
1. Extracting information from several single nucleotide polymorphism (SNP)/genes to create 
stronger instrumental variables than a single SNP/gene. 
2. Possibility of allocating multiple instrumental variables to a transcript to explain the variation of 
the transcript sufficiently.   
3. Generating independent instrumental variables to avoid violation of the assumptions, due to 
genetic variants’ properties such as pleiotropic effect.  
 
Figure 2. Visualization of some features of the G-DAG algorithm. White: generated instrumental variables 
from multiple SNPs. Brown: variables of interest here transcripts. The aim is identification of underlying 
relationship between the transcripts (browns) using the instrumental variables (whites). 
These features of the G-DAG algorithm provide opportunities to explain the variation in transcripts that 
are due to genetic variants and free of confounding. 
Transcript of 
interest        
IV 
Confounder 
Outcome 
transcript  
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Materials and methods 
Study sample: The RNA sequence (RNA-seq) data are from post-mortem dorsolateral prefrontal cortex 
which controls complex, higher-level cognitive and executive functions. These data are available in 
CommonMind Consortium (CMC; http://www.synapse.org/CMC). Following data normalization, 16,423 
genes (based on Ensembl models) were expressed at levels sufficient for analysis, of which 14,222 were 
protein-encoding. Validation using PCR showed high correlation (r > 0.5) with normalized expression 
from RNA-seq for the majority of genes assessed. Covariates for RNA integrity (RIN), library batch, 
institution (brain bank), diagnosis, age at death, genetic ancestry, post-mortem interval and sex together 
explained a substantial fraction (0.42) of the average variance of gene expression and were thus 
employed to adjust the data for the analyses (Fromer et al., 2016). 
Samples were genotyped on the Illumina Infinium HumanOmniExpressExome array (958,178 single-
nucleotide polymorphisms, or SNPs). These genotypes were used to detect SNPs that have an effect on 
gene expression, to estimate ancestry of the samples and to ensure sample identity across DNA and 
RNA experiments. The distribution of ethnicities shows Caucasian 80.7%, African-American 14.7%, 
Hispanic 7.7%, East Asian 0.6%. To prevents the study be confounded due to different ethnicities, we 
included 80.7% Caucasian (209 samples) in this study.   
Methods 
To investigate complex networks among transcripts utilizing Mendelian randomization technique, we first 
generated instrumental variables from genetic variants across the genome. Through this approach, only 
a few instrumental variables significantly were found related to the transcripts. The result was consistent 
with the fact that gene transcription is strictly controlled by the interplay of regulatory events at gene 
promoters and gene-distal regulatory elements called enhancers. Therefore, we concluded that gene 
expression is affected by genetic variations nearby genes (orientation, position, and distance) (Yazdani et 
al.,  2017). This result is also reported recently by (Aguet et al., 2017). To generate the IVs based on 
genetic variants nearby genes, we included variants in 40 kb upstream of transcription start site (TSS) 
and 40kb downstream of transcription end site (TES) to involve variants in genes and their promoters. In 
addition, we used high-resolution 3D maps of chromatin (Hi-C) (Won et al., 2016) for reflecting the 
secondary structure properties of looped DNA within a nucleus. By selecting those variants, we aimed to 
consider the variants that mediate the effects of cis-regulatory elements via both short- and long range 
interactions.  
 
To generate instrumental variables and  fulfill the underlying assumptions, we applied multiple 
correspondence analysis (Ng et al., 2009) over a set of variants nearby each gene. The method multiple 
correspondence analysis, which is a part of a family of descriptive methods, is the multivariate extension 
of correspondence analysis to analyze tables containing three or more variables. In addition, multiple 
correspondence analysis is considered as a generalization of principal component analysis for 
categorical variables and allows to investigate the pattern of relationships of several categorical variables 
in complex data sets. Despite principal component analysis, multiple correspondence analysis is not 
limited to linear relationship among genetic variants and has the ability to identify their non-linear 
relationship for generating instrumental variables. 
 
After generating instrumental variables, we applied the G-DAG algorithm to build transcriptomic network 
and employed Hamming distance (Tsamardinos, Brown and Aliferis, 2006) to assess quality of the fit in 
identified network. The G-DAG algorithm selects the generated instrumental variables that have 
significant relationship with the transcripts. The instrumental variables help identify robust directions 
across Bayesian networks that are not identified through interaction among genes (Yazdani et al., 
2016a). The stability of the identified Bayesian networks in observational study is established in 
Mendelian principles since the genetic inherited variation is the cause of phenotypic variation (here gene 
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expression). Therefore, these stable Bayesian networks are called causal networks in observational 
studies (Pearl, 2000; Sheehan et al., 2008; Yazdani et al., 2016c).  
 
Results 
We generated 4,641 IVs from 958,178 SNPs and identified the transcriptomic network over a set of 1,181 
transcripts. These transcripts are belongs to a class of genes with highest number of SCZ associated 
gene in an study by Fromer et al. (2016). We mapped the SCZ associated genes on the identified 
transcriptomic network with blue colors presented in Figure 3. The identified transcriptomic network 
revealed underlying relationships (pathways) among genes. To extract information from the 
transcriptomic network, we measured the network properties, including high impact genes and modules. 
 
Figure 3. Left: Identified transcriptomic causal network. Each node stands for a gene. Genes associated with 
SCZ are depicted in blue. Right: A zoom out relationships among some genes in the network. 
High impact genes: Some genes relative to others have high impact in the system (directly/indirectly) 
due to having a high out-degree and a high number of maximum effect-blocking-step (Yazdani et al., 
2016b). Out degree refers to the number of genes directly affected by a gene. It represents the impact of 
a gene in the system. For instance, RAB30 in Figure 3, right panel, has 3 out-degree. The effect of a 
gene can be propagated serially, until reaching a blocking gene which is a gene with zero out-degree. In 
Figure 3 right panel, ZNF770, LCOR, MAP3K2 and MOB1B are the blocking genes. The effect blocking 
step of a gene is defined as the number of genes influenced by a gene in one path before the effect gets 
blocked. SENS3 and LRRC58 are identified with the effect blocking step equal to one in all paths in the 
right panel. The maximum number of effect blocking steps across all the paths of a gene is called the 
max effect blocking step, which is 2 for RAB30. The low max effect blocking step of a gene represents 
that the indirect impact of the gene on the transcriptomic network is not high.  
Some of the properties of the identified transcriptomic network are summarized in Figure 4 by focusing on 
SCZ associated genes. The figure on the left side, summarizes the impact of SCZ associated genes in 
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the system. The figure on the right side clusters the SCZ associated genes based on type of studies that 
previously found the association.  
            
Figure 4. Left: represents the in-degree and out-degrees of genes associated with SCZ in the network. Right: 
Vann diagram cluster those genes based on the type of studies that previously found their association with 
SCZ.  
 
Modules: A module includes genes influenced by a high impact gene directly or indirectly. We identified 
several modules across the transcriptomic network with a focus on SCZ associated genes summarized in 
Table 1. Through further analyses of the modules, we discussed the gene-gene underlying relationships 
(pathways) to identify novel SCZ associated genes and intervention targets summarized in Table 2. For 
each module, a heatmap is provided to present the strength of the pathways based on the p-values’ cut-
off. Moreover, we analyzed the gene ontology for each module represented below. Due to space 
limitation, the modules are depicted as a sub-network.  
Table 1 summarized the main features of the identified modules; name of the hub, number of genes in the 
module, the number of genes influenced by the hub in the longest path (Max effect blocking step), the 
number of genes associated to SCZ and the gene ontology. 
Module SCZ #genes 
# SCZ 
associated 
genes 
Max effect 
blocking step 
Gene ontology 
NRXN3 SCZ-GWAS 9 3 2 Gene Expression, RNA damage & repair, RNA post-
transcriptional modification 
COMT  Psych-cnv 12 2 2 Drug Metabolism, Molecular Transport, Cell-To-Cell 
Signaling & Interaction 
PEX5L  
 
----- 10 2 4 Cellular development, cellular Growth & proliferation, 
nervous system development & function 
MYH10  SCZ-denovo-
nonsyn 
10 2 3 cellular development, cellular growth & proliferation, 
nervous system development & function 
TENM3 -----         10   5 4 cellular Movement, reproductive system development 
& function, cardiovascular system development & 
function 
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Table 2. hypotheses made through further analysis of the transcriptomic causal network.  
 
 
 
 
 
NRXN3-Module: NRXN3 as the hub of the identified transcriptomic modules encodes a member of a 
family of proteins that function in the nervous system as receptors and cell adhesion molecules. NRXN3 
is reported as SCZ associated gene (Hu et al., 2013) through genome wide association study. The 
module includes 6 genes influenced by NRXN3 directly (ARFGEF3, HECW2, SORCS3, DLGAP1, 
CNTNAP2) and indirectly (RNF150) while its effects are blocked in the module after one or two steps.  
 
                              
Figure 5. Left: NRXN3-Module with multiple SCZ associated genes depicted in blue. Right: heatmap of the 
strength of the pathways based on the p-values’ cut-off. 
 
 
As Figure 5 shows, the longest path in this module is MAS1 NRXN3 SORCS3 RNF150 which 
includes two genes associated with SCZ presented in blue. Therefore, we hypothesize that RNF150 is 
probably associated to SCZ as well. The strongest pathway in this module is MAS1 NRXN3 
CNTNAP2.  
The network reveals that MAS1 has impact on NRXN3 and FREM3 while the impact on NRXN3 is much 
higher. NRXN3 distributes the effect of MAS1 into the system although FRM3 blocks the effect of MAS1. 
Interestingly, the gene ontology analysis shows that all genes in the module except FRM3 have similar 
function related to “gene expression, RNA damage and repair, RNA post transcriptional and 
modification”. FRM3 that blocks the effect of MAS1 does not have the same functionality as MAS1 and 
its functionality is related to “cellular Growth and proliferation, organismal development and cell cycle”. 
Therefore, MAS1 is a good target for intervention since it is the cause of SCZ associated gene, NRXN3, 
with high impact and similar function. 
Hypotheses 
SCZ associated genes Intervention target for SCZ associated genes 
Genes Modules Target SCZ  associated genes 
GRIN3A NRXN3-Module MAS1             NRXN3 
RNF150             NRXN3-Module PEX5L STARD13 
ANK2                MYH10-Module PEX5L                                        DLG2 
GRIN3A           TENM3-Module  
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COMT-Module: Catechol-O-methyltransferase (COMT) is one of the hubs with impact on 10 genes in the 
identified transcriptomic network. Figure 6 shows underlying relationships among these genes where the 
effect of COMT is blocked after at most two steps. The strongest path in the module is through DCXR  
(COMT DCXR YIF1A).  
                  
Figure 6. COMT- Module with a hub associated with SCZ in blue. Right: heatmap of the strength of the 
pathways based on the p-values’ cut-off. 
Based on gene ontology analysis, the COMT-Module is related to “Drug Metabolism, Molecular 
Transport, Cell-To-Cell Signaling and Interaction”. COMT plays an essential role in the module by 
influencing multiple genes from the same functionality based on gene ontology. This information makes 
COMT a good target for intervention, which is discussed with more details in the discussion section.  
GLI4 is the only gene that does not have similar function as the other genes in the module. GLI4 is a 
blocking effect gene in the boundary of the module with a moderate effect from COMT (see the right 
panel in Figure 5). As Figure 5 shows, two other genes from outside the module influence GLI4. The 
different functionality of GLI4 is due to the larger effect size on GLI4 from outside of module compared to 
the inside. 
MYH10-Module: MYH10 is an associated SCZ gene influencing 7 genes in the network while influenced 
by two genes (ADAM23 and CHD6). The longest path that spreads the effect of MYH10 in the system is 
CHD6MYH10LMO7RTF1HMG20A. This path is also the strongest path in this module.   
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Figure 7. MYH10- Module with a hub associated with SCZ in blue. Right: heatmap of the strength of the 
pathways based on the p-values’ cut-off. 
 
Figure 7 shows a path of three genes (MYH10ANK2 DLG2) while two of these genes are associated 
with SCZ identified via de novo LoF mutation studies. Therefore, we hypothesize that ANK2 is potentially 
associated with SCZ. Gene ontology analysis categorized all genes in MKLN1 module with similar 
Function, “cellular development, cellular growth and proliferation, nervous system development and 
function”. 
PEX5L-Module: PEX5L is the hub of this module with significant impacts on two genes associated with 
SCZ (STARD13 and DLG2). The strong relationship between PEX5L and these two genes make PEX5L 
a good target for intervention in the study of SCZ. Considering the underlying relationship of PEX5L 
provides insights on designing for the intervention and better understanding of its effect in the system. 
 
                  
Figure 8. PEX5L-Module with a hub associated with SCZ in blue.  Right: heatmap of the strength of the 
pathways based on the p-values’ cut-off. 
 
As Figure 8 shows, the direction of PALM2 is not identified through this analysis. While PALM2 is in the 
edge of the network and no IVs affected on this gene, we hypothesize that PALM2 may be affected by 
the genes that are not included in this study. Gene ontology shows all genes in PEX5L-Module including 
PALM2 have similar function related to “Cellular development, cellular Growth and proliferation, nervous 
system development and function”.  
TENM3-Module: TENM3 is a SCZ associated gene with impact on 10 genes in the network while 4 of 
them are associated with SCZ. The longest path in this network is TENM3 GRIN3A GRIA1 
SORCS3 RNF150. In this pathway, all the genes are associated with SCZ except GRIN3A and 
RNF150. We can make a strong hypothesis that GRIN3A is an SCZ associated gene since it is 
influenced only by one gene which is associated to SCZ and GRIN3A itself influences 3 genes 
associated with SCZ directly or indirectly.  RNF150 may also be associated with SCZ since it strongly 
influenced by SORCS3 and not by SEZ6L.  
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Figure 9. TENM3- Module with a hub associated with SCZ in blue. Right: heatmap of the strength of the 
pathways based on the p-values’ cut-off. 
 
Gene ontology shows that all genes in this module are related to functionality “cellular Movement, 
reproductive system development and function, cardiovascular system development and function”.  
Discussion  
Revealing the underlying relationships among genes is complementary to experimental study through 
facilitating mechanistic understanding and providing insights to pathology of disease and treatment.  
Focusing on SCZ as a heritable complex mental disorder, we selected a cluster of 1181 genes with a 
large number of schizophrenia associated genes from the study by Fromer, et al. (2016). To construct 
causal network in observational study, we modified the G-DAG algorithm for RNA-seq data, which is an 
algorithm based on Mendelian randomization and Bayesian graphical modeling. We utilized the fact that 
genetic variants are the cause of substantial variation in transcriptomic level and therefore, extracted 
information from 958,178 genetic variants (SNPs) and identified underlying relationships among the 
transcriptomics. Mapping the SCZ associated genes on the network, we elicited information from the 
network such as, transcriptomic modules, high impact genes and underlying pathways in the system to 
provide a mechanistic understanding. 
This study provides the first algorithm to reveal underlying relationships among schizophrenia candidate 
genes in large scale. Our preliminary results suggest that this systems approach is likely to lead to 
establishing etiological mechanisms of disorder, including psychiatric illness. Our examination of the 
network showed that the impact of a specific gene is on few genes and does not spread across the 
system. In addition, we hypothesized some genes associated to the disorder as well as causes of the 
associated genes and targets for intervention. Furthermore, the underlying gene relationship provided 
some insights into how designing the intervention.  
We hypothesized the gene MAS1 as an intervention target for the SCZ associated gene NRXN3. The 
revealed pathways provide some insights that how the effect of an intervention in the gene MAS1 
spreads through the system and how disease mechanism may break down these pathways. Analyses of 
TENM3 module shows that GRIN3A directly and indirectly influences 3 genes associated with SCZ. 
Furthermore, GRIN3A is influenced by only one gene which is associated to SCZ too. This information 
hypothesized that GRIN3A itself is also a SCZ associated gene.  
COMT was identified as a good target for intervention since it is not influenced by any gene and 
influenced multiple genes from the same functionality, based on gene ontology. COMT is an important 
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regulator of a number of cognitive and behavioral processes due to its role in the termination of 
dopamine signaling in brain regions such as the prefrontal cortex and hippocampus. There are many 
studies (e.g. Saravani, 2017 ; Bhakta, 2012) on brain-penetrating inhibitors of COMT for curing a variety 
of conditions associated with dysregulated cortical dopaminergic function like schizophrenia. However, 
the known brain penetrant COMT inhibitors nitrocatechol tolcapone has serious safety issues that 
preclude widespread use in psychiatric disorders. Therefore, understanding COMT systematic effect on 
other genes provides insights into its functional mechanism in the brain and is useful for treatment of 
neurologic disorders such as SCZ (Barrow and Akuma, 2017).  
Identifying underlying pathways among genes reveals important biological relationships among 
molecular components and leads to understanding complex biological mechanisms, disease 
pathogenesis, and underlying co-morbidities (Zhernakova, Van Diemen and Wijmenga, 2009; Lee et al., 
2012). This understanding may improve and speed drug development and furthermore, predict possible 
side effects (van de Peppel and Holstege, 2005; Williams, 1957). Although systems approaches to 
molecular pathway identification will not replace mechanistic experiments, they are complementary and 
hypothesis-generating especially in the age of large scale data to narrow the search space, identify 
targets for intervention, and follow the effect of any intervention in the system.  
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